financetom
Business
financetom
/
Business
/
China's Nio, behind on growth targets, aims to tighten cost control
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
China's Nio, behind on growth targets, aims to tighten cost control
Dec 12, 2024 1:41 AM

SHANGHAI (Reuters) -Chinese electric vehicle (EV) maker Nio will seek to improve efficiency and cost control as it seeks to spur sales growth that is two years behind schedule, its CEO said on Thursday.

William Li told reporters at an event in Shanghai that it will also start production at its third factory in the second half of next year, and that it aimed to achieve monthly deliveries of 20,000 cars from its second, Onvo brand, by March 2025.

The company has had 30-40% growth in the last three years but that was not satisfactory, he said. Li said last month the company aims to double sales in 2025 from this year.

Nio, one of China's largest EV players by sales, has been fighting price competition in China by broadening its customer base and boosting sales with cheaper models. The company has also trimmed its workforce and deferred long-term projects that would not contribute to financial performance within three years.

It launched its affordable Onvo brand in May, with the Onvo L60 SUV with a sticker price starting at 219,900 yuan ($30,300). Tesla's Model Y starts at 249,900 yuan in China.

Asked about the United States' latest curbs on semiconductor-related exports to China, Li said they were evaluating the impact.

There were sufficient domestic alternatives for high computing power chips in cars but a bigger challenge was to replace the hundreds of thousands of foreign chips in EVs that cost $1 or $2 each with domestic options, he said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Plus Therapeutics Gets $3 Million Funding Recommendation From Department of Defense
Plus Therapeutics Gets $3 Million Funding Recommendation From Department of Defense
Apr 22, 2024
10:15 AM EDT, 04/22/2024 (MT Newswires) -- Plus Therapeutics ( PSTV ) said Monday it has been selected for a $3 million funding recommendation from the US Department of Defense office of the Congressionally Directed Medical Research Programs. The award is expected to start in Q3 and will help expand its clinical trial for pediatric brain cancer, the company said....
Lower prices, stubborn costs could weigh on copper miners' quarterly results
Lower prices, stubborn costs could weigh on copper miners' quarterly results
Apr 22, 2024
(Reuters) - North American copper miners are expected to report a decline in first-quarter earnings this week due to lower prices of the red metal amid persistently high costs. Freeport-McMoRan ( FCX ) and Canada's Teck Resources ( TECK ) are expected to post a combined adjusted net income of $666.3 million, according to LSEG estimates, compared with $1.43 billion...
Update: CoStar to Buy Matterport in Cash, Stock Deal Valued at $5.50 per Share
Update: CoStar to Buy Matterport in Cash, Stock Deal Valued at $5.50 per Share
Apr 22, 2024
10:05 AM EDT, 04/22/2024 (MT Newswires) -- (Updates with additional details starting from third paragraph.) CoStar ( CSGP ) agreed to acquire Matterport ( MTTR ) in a cash-and-stock deal valued at $5.50 per share, reflecting an enterprise value of an estimated $1.6 billion, the companies said Monday. Under the deal, Matterport ( MTTR ) shareholders will get $2.75 in...
Intrusion to Buy Minority Stake in Klever AI
Intrusion to Buy Minority Stake in Klever AI
Apr 22, 2024
10:10 AM EDT, 04/22/2024 (MT Newswires) -- Intrusion (INTZ) said Monday it has agreed to buy a minority stake in artificial intelligence company Klever AI in an all-stock deal. Financial details weren't provided. Intrusion shares were down 10.6% in recent trading. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved